Breaking News
'KICKBACK' SCHEME: Nick Shirley EXPOSES alleged NYC senior daycare center fraud
Oil prices are in free fall and could keep going to $40. Which implies $2 gasoline.
Can 'Spaceballs 2' Be As Good As Its Marketing Campaign?
He Risked Everything To Warn You: No One Is Ready For What's Coming...
Top Tech News
Modular Reactors To Solve Data Center Hysteria?
DeepSeek Developing In-House AI Chip In Bid To Cut Nvidia Reliance
America just took three brand-new nuclear reactors critical in thirty days, a first for any...
Your brain doesn't peak in your 20s after all: Study reveals your mind is at its sharpest betwee
Compasses, not maps: China is building a different type of AI
The Return of the Ekranoplan
Farewell, atom-smashing Large Hadron Collider
This is already starting.
The Crosley IcyBall
It's Not a Conspiracy Anymore: Med Beds Exist and Trump Knows It
Tumor-Destroying Sound Waves Treatment Coming to a Hospital Near You For Liver Cancer
Known as "histotripsy," the method and machinery have already been tested successfully in animals and humans, and has just been approved for use by the FDA.
HistoSonics is a company founded in 2009 to create an ultrasound device that both screens for tumors and administers histotripsy. It was born from the efforts of scientists at the University of Michigan who co-founded the firm.
"Histotripsy is an exciting new technology that, although it is in early stages of clinical use, may provide a noninvasive treatment option for patients with liver cancer. Hopefully it can be combined with systemic therapies for a synergistic therapeutic effect," said Mishal Mendiratta-Lala, professor of radiology with Michigan Medicine.
Mendiratta-Lala was the principal investigator of an FDA human trial started in 2021 which confirmed that HistoSonic's device, called Edison, can destroy cancer tumors.